Assignee
BLUEJAY THERAPEUTICS INC
US·0 granted patents·4 pending applications·0 citations·filing 2023–2024
Top patents by PatentIndex Score
4 records- 0167US2025026745A117-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereofBLUEJAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0266US2024182472A1Indazole pyridone compounds and uses thereofBLUEJAY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0364US2025009899A1Fusion proteins containing il21 muteins for treating cancer and viral diseasesBLUEJAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0463US2024400650A1Anti-HBsAg antibody for treatment of chronic hepatitis DBLUEJAY THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BLUEJAY THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →